Carbamazepine and cardiac conduction disturbances

Area of Science:

• Cardiology
• Neurology
• Pharmacology

Background:

• Epilepsy management often involves carbamazepine, an anticonvulsant medication.
• Cardiac conduction abnormalities are a potential, though infrequently reported, adverse effect of carbamazepine therapy.

Observation:

• Two patients with epilepsy experienced cardiac conduction disturbances.
• These cardiac defects were temporally associated with carbamazepine treatment.

Findings:

• Carbamazepine discontinuation led to the resolution of cardiac defects in both patients.
• Re-challenge with carbamazepine resulted in the reappearance of cardiac conduction disturbances in one patient, confirming a causal link.

Implications:

• Clinicians should monitor for cardiac conduction abnormalities in patients treated with carbamazepine.
• The findings highlight the importance of considering drug-induced cardiotoxicity in epilepsy patients presenting with cardiac symptoms.